SCHEMBL28220103

SCHEMBL28220103

COC1(OC)CCN(C[C](C)C)CC1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3390865 0.82
SCHEMBL28310816 0.72
SCHEMBL2704498 0.68 ATM (0.31)
SCHEMBL28844970 0.67 SLC6A3 (0.44)
SCHEMBL5226088 0.64 HTR2A (0.31)
SCHEMBL27678892 0.63 ALDH1A1 (0.35)
SCHEMBL27930049 0.63 ALDH1A1 (0.35)
SCHEMBL27780419 0.63 ALDH1A1 (0.35)
SCHEMBL27774080 0.63 LTA4H (0.35)
SCHEMBL27880307 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106631992-A Synthesis method of 4-oxy-3,4-dihydro-2H-pyridine-1-tert-butyl formate 桑迪亚医药技术(上海)有限责任公司 2017-05-10 CN claimed
CN-106631992-B A kind of synthetic method of 4- oxygen -3,4- dihydro -2H- pyridine -1- t-butyl formate 桑迪亚医药技术(上海)有限责任公司 2019-01-18 CN disclosed
CN-104650049-B Substituted pyridine compounds and its application method and purposes 广东东阳光药业有限公司 2018-06-08 CN disclosed